◄ back to all posts
Financial data and stock pages provided by
Fintel.io
◄ back to all posts
MRK: Merck & Co., Inc. Stock
Written by | Jul 6, 2018
Print FriendlySIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 196,029.14 |
| Enterprise Value ($M) | 213,006.62 |
| Book Value ($M) | 25,317.00 |
| Book Value / Share | 10.01 |
| Price / Book | 7.64 |
| NCAV ($M) | n/a |
| NCAV / Share | n/a |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.13 |
| Return on Assets (ROA) | 0.08 |
| Return on Equity (ROE) | 0.27 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.79 |
| Current Ratio | 1.02 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 27,764.00 |
| Assets | 91,588.00 |
| Liabilities | 66,271.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 47,994.00 |
| Operating Income | n/a |
| Net Income | 7,082.00 |
| Earnings Per Share Diluted | 2.78 |
| Earnings Per Share Basic | 2.79 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 10,253.00 |
| Cash from Investing | -9,443.00 |
| Cash from Financing | -9,443.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Vanguard Group Inc | 8.24 | -1.01 | |
| 13G/A | BlackRock Inc. | 7.80 | 2.85 | |
| 13G/A | Capital World Investors | 3.20 | -36.57 | |
| 13G/A | Wellington Management Group Llp | 4.50 | -31.76 | |
| 13G/A | Capital Research Global Investors | 2.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| Annual Report – 10-K | ||
| Quarterly Report – 10-Q | ||
| Quarterly Report – 10-Q | ||
| Quarterly Report – 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 895,917 | 11,937,900 | 7.50 | |
| 880,446 | 13,875,686 | 6.35 | |
| 583,563 | 8,030,134 | 7.27 | |
| 475,068 | 8,232,240 | 5.77 | |
| 983,682 | 9,513,983 | 10.34 | |
(click for more detail) |
|||
(click for list of largest short owners) |
|||
| Similar Companies | |
|---|---|
| JNJ – Johnson & Johnson | LCI – Lannett Company, Inc. |
| LLY – Eli Lilly And Co | NUVB – Nuvation Bio Inc |
| NVO – Novo-Nordisk A/S |
Financial data and stock pages provided by
Fintel.io
2018/07/06
